Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2016-03-18 Major Shareholding Noti…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding by Danske Bank A/S concerning Orexo AB's ordinary shares. It explicitly lists the 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures for shares and voting rights, culminating in a 'Resulting distribution of total holdings'. This structure perfectly matches the definition of a Major Shareholding Notification, which is classified under the code MRQ.
2016-03-18 English
AstraZeneca förvärvar alla rättigheter till Orexos OX-CLI-projekt
M&A Activity Classification · 1% confidence The document is titled "Pressmeddelande" (Press Release) and announces a specific corporate transaction: AstraZeneca exercising an option to acquire all rights to Orexo's OX-CLI project for $5 million, plus future milestones and royalties. This is a material event announcement concerning a business transaction (M&A/licensing activity). While it relates to drug development, its primary function is to announce the completion of a transaction based on a prior option agreement. This fits best under 'M&A Activity' (TAR) or potentially a general 'Regulatory Filing' (RNS) if TAR is too specific for a licensing deal. Given the nature of acquiring rights to a program, TAR (Merger/Takeover Activity) is the closest fit among the specific codes, as it involves a significant transfer of assets/rights, even if it's not a full company takeover. Since it is a formal announcement of a completed transaction, it is not a Report Publication Announcement (RPA).
2016-03-17 Swedish
AstraZeneca acquires all rights to Orexo´s OX-CLI project
M&A Activity Classification · 1% confidence The document is titled 'Press release' and announces a specific corporate transaction: AstraZeneca acquiring all rights to Orexo's OX-CLI project for a set payment plus future milestones and royalties. This describes a corporate transaction, specifically related to asset acquisition and licensing rights within the pharmaceutical sector. This type of announcement, detailing a significant business development (M&A/Asset Transfer), fits best under the 'M&A Activity' category (TAR), as it involves the transfer of significant development rights between two companies. It is not a standard regulatory filing (10-K, IR), an earnings release (ER), or a management change (MANG). Since it is a definitive announcement of a transaction, TAR is the most appropriate fit.
2016-03-17 English
Kallelse till årsstämma i Orexo
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i Orexo" (Notice of Annual General Meeting in Orexo) and details the date, time, location, registration procedures, proposed agenda items (including election of board members, approval of remuneration guidelines, and authorization for share issues/repurchases), and specific proposals related to the AGM. The agenda explicitly covers items typically found in an Annual General Meeting notice, such as the presentation of the annual report (item 8) and decisions on profit distribution (item 11). This content strongly indicates a formal notice for an Annual General Meeting, which corresponds to the AGM-R code, although the content is the notice itself, not the presentation materials. However, since the document is a formal call for the meeting and details the agenda and proposals to be voted on, AGM-R is the most appropriate classification among the choices, as it relates directly to the AGM event. It is not a DEF 14A (Proxy Statement) as it is a Swedish 'Kallelse' (Notice) and not a US proxy filing, nor is it a 10-K (Annual Report) itself, but rather the notice convening the meeting where the annual report will be presented.
2016-03-11 Swedish
Notice of Annual General Meeting of Orexo
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of Orexo" and details the date, location, procedures for shareholder participation, and the full agenda for the meeting. The agenda items cover the election of the chairman, approval of financial statements (Annual Report presentation), election of the board, remuneration guidelines, and authorizations for share issuance/repurchase. This content is characteristic of the official notice and materials distributed for an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2016-03-11 English
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release dated February 29, 2016, announcing a change in the total number of shares and votes due to the exercise of warrants related to incentive programs. This directly relates to a change in the company's capital structure (share count). Reviewing the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category, as it covers changes in the number of shares outstanding. It is not an earnings release (ER), a dividend notice (DIV), or a director's dealing (DIRS). The length is short, but the content is a direct announcement of a capital change, not an announcement *about* a report, making SHA more specific than RPA or RNS.
2016-02-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.